UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH)
UnitedHealth Group Incorporated is a diversified healthcare company based in the United States. It operates primarily through two segments: UnitedHealthcare, which provides health insurance and benefits services, and Optum, which offers health services including pharmacy care, healthcare technology, and information-intensive services. Established in 1977 and headquartered in Minnetonka, Minnesota, UnitedHealth Group is one of the largest healthcare organizations globally, focusing on improving health care access, affordability, and quality.
Dividend History
Investors can expect a dividend payout of $2.21 per share, scheduled to be distributed in 3 days on September 23, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 23, 2025 | $2.21 | 2025-09-15 | 2025-09-15 |
| June 24, 2025 | $2.21 | 2025-06-16 | 2025-06-16 |
| March 18, 2025 | $2.10 | 2025-03-10 | 2025-03-10 |
| December 17, 2024 | $2.10 | 2024-12-09 | 2024-12-09 |
| September 24, 2024 | $2.10 | 2024-09-16 | 2024-09-16 |
Dividends Summary
- UNITEDHEALTH GROUP INCORPORATED (Delaware) has issued 69 dividend payments over the past 21 years
- The most recent dividend was paid 88 days ago, on June 24, 2025
- The highest dividend payed out to investors during this period was $2.21 per share
- The average dividend paid during this period was $0.84 per share.
Company News
Hedge fund manager David Tepper believes stocks are overvalued but remains invested due to anticipated Federal Reserve rate cuts, expressing mixed feelings about current market conditions.
In August 2025, UnitedHealth Group, Intel, and Newmont experienced significant stock gains driven by unique factors including Berkshire Hathaway's investment, government support, and rising gold prices.
The article highlights 8 Warren Buffett-backed stocks with potential upside during September market volatility, focusing on stocks with strong valuation and performance metrics.
The AI in Medical Billing Market is projected to grow from USD 3.69 billion in 2024 to USD 22.46 billion by 2032, driven by healthcare industry needs for automation, accuracy, and regulatory compliance.
Elevance Health reported strong Q2 2024 earnings, with adjusted EPS of $10.12 beating estimates. However, the company saw a decline in medical membership and premium revenues, impacting overall margins. The results were driven by improved product revenues in the CarelonRx business and higher net investment income.
